This compound is a deuterated derivative of a quinazoline-based active pharmaceutical ingredient, supplied as the hydrochloride salt. It is characterized by a multi-ring aromatic structure and multiple ether and amine functional groups, reflecting its role as a pharmaceutical raw material.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1276197-14-8
(R)-(-)-Phenylephrine-d3 HCl
pharmaceutical raw material
(S)-Pregabalin-d4
pharmaceutical raw material
Pantoprazole sulfone
pharmaceutical raw material
Epinastine hydrobromide
pharmaceutical raw material
Alfuzosin hydrochloride
pharmaceutical raw material
Alfuzosin
pharmaceutical raw material
N-{3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)amino]propyl}-N-methyloxolane-2-carboxamide--hydrogen chloride (1/1)
pharmaceutical raw material
N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)amino)propyl)-N-methyltetrahydrofuran-2-carboxamide
pharmaceutical raw material
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]-2,3,3,4,4,5,5-heptadeuteriooxolane-2-carboxamide;hydrochloride
YTNKWDJILNVLGX-IMFUZPKQSA-N
[2H]C1(C(C(OC1([2H])[2H])([2H])C(=O)NCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC)([2H])[2H])[2H].Cl